"epidermal cell" trang 6 - tải miễn phí từ tailieunhanh
Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWDbinding protein induce cell differentiation in gastric cancer

Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWDbinding protein induce cell differentiation in gastric cancer
14    40    1
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients
7    31    1
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
12    34    1
Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer
8    41    1
Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker

Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
8    52    1
OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2

OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2
11    31    1
Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors

Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
10    46    1
Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
9    52    1
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs
12    51    1
EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
10    72    1
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
9    42    1
Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer
7    39    1
Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies
9    44    1
LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8

LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8
13    23    1
Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations

Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations
13    20    1
EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma

EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma
9    26    1
Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations

Genetic and treatment profiles of patients with concurrent Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) mutations
8    23    1
The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation

The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation
8    29    1
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: A systematic review and meta-analysis of 11 randomized controlled trials

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: A systematic review and meta-analysis of 11 randomized controlled trials
14    1    1
Prognostic value of CYFRA 21−1 and Ki67 in advanced NSCLC patients with wild-type EGFR

Prognostic value of CYFRA 21−1 and Ki67 in advanced NSCLC patients with wild-type EGFR
10    3    1